A28 – The Role of the Patient in Pharmacovigilance

In this session, we aim to discuss learnings from the increase in patient engagement and reporting in the EU over past five, years including experiences using apps/social media, as well as gain TGA insights into patient reporting and the quality of resulting data. In what ways can PV add value to patients?

Chairperson: Nastassia Lukass, Novartis